CARDIOVASCULAR THERAPY AND PREVENTION · 2021 · 22 citations · 17 references
MedicinePharmacotherapyRehabilitation MedicinePulmonary RehabilitationRehabilitationRespiratory PharmacotherapyInhalation TherapyRecovery StrategiesRespiratory RehabilitationProphylactic Inhalation TherapyRecovery Period AssessmentRehabilitation Program Management
Active hydrogen inhalation (H(H 2 O) m ) has powerful antioxidant and antiapoptotic effects. In recent years, it has been used in a number of experimental and clinical studies. Aim. To study the safety and effectiveness of inhalation of the “active form of hydrogen” (AFV;(H(H 2 O) m )) in the rehabilitation program of coronavirus disease 2019 (COVID-19) survivors during the recovery period. Material and methods . This randomized controlled parallel prospective study included 60 COVID-19 survivors with post-COVID-19 syndrome (ICD-10: U09.9) during the recovery period, with clinical manifestations of chronic fatigue syndrome (CFS), who received standard therapy in accordance with the management protocol of patients with CFS (ICD-10: G93.3): physiotherapy and medication therapy with drugs containing magnesium, B vitamins and L-carnitine. The patients were divided into 2 groups. The experimental group (n=30) included patients who received hydrogen inhalation for 90 minutes every day during 10 days (SUISONIA hydrogen inhalation device, Japan). The control group (n=30) consisted of patients who received standard therapy. In both groups, patients were comparable in sex and mean age: in the experimental group — 53 (22; 70) years, in the control group — 51 (25; 70) years. Biological markers of systemic inflammation, oxygen transport, lactate metabolism, intrapulmonary shunting, 6-minute walk test, and vascular endothelial function were determined in all patients on the 1 st and 10 th days of follow-up. Results. In the experimental group, a decrease in following parameters was revealed: stiffness index (SI), from 8,8±1,8 to 6,8±1,5 (p<0,0001); ALT, from 24,0±12,7 to 20,22±10,61 U/L (p<0,001); venous blood lactate, from 2,5±0,8 to 1,5±1,0 mmol/L (p<0,001); capillary blood lactate, from 2,9±0,8 to 2,0±0,8 mmol/L (p<0,0001); estimated pulmonary shunt fraction (Qs/Qt, Berggren equation, 1942) from 8,98±5,7 to 5,34±3,2 (p<0,01); white blood cells, from 6,64±1,57 to 5,92±1,32 109/L. In addition, we revealed an increase in the refractive index (RI) from 46,67±13,26% to 63,32±13,44% (p<0,0001), minimum blood oxygen saturation (SpO 2 ) from 92,25±2,9 to 94,25±1, 56% (p<0,05), direct bilirubin from 2,99±1,41 to 3,39±1,34 pmol/L (p<0,01), partial oxygen tension (PvO 2 ) from 26,9±5,0 to 34,8±5,6 mm Hg (p<0,0001), venous oxygen saturation (SvO2) from 51,8±020,6 to 61,1±018,1% (p<0,05), partial capillary oxygen tension (PcO 2 ) from 48,7±15,4 to 63,8±21,2 mm Hg (p<0,01), capillary oxygen saturation (ScO 2 ) from 82,2±4,2 to 86,2±4,8% (p<0,01), distance in 6 minute walk test from 429±45,0 to 569±60 m. Conclusion. Inhalation therapy with H(H 2 O)m in the rehabilitation program of COVID-19 survivors during the recovery period is a safe and highly effective method. Manifestations of silent hypoxemia and endothelial dysfunction decreased, while exercise tolerance increased. As for laboratory tests, a decrease in the white blood cell count, estimated pulmonary shunt fraction and lactate content parameters was revealed.
17
Attributes and predictors of long COVID
Carole H. Sudre, Benjamin Murray, Thomas Varsavsky et al. · Nature Medicine · 2021 · 2.6K citations · Full text
Extracellular DNA traps promote thrombosis
Tobias A. Fuchs, Alexander Brill, Daniel Duerschmied et al. · Proceedings of the National Academy of Sciences · 2010 · 2.4K citations · Full text
Medicine, Immunology, Pathobiology +17
Multiple organ infection and the pathogenesis of SARS
Jiang Gu, Encong Gong, Bo Zhang et al. · The Journal of Experimental Medicine · 2005 · 1.4K citations · Full text
Hyperbaric hydrogen Therapy: A Possible Treatment for Cancer
Malcolm Dole, Frank R. Wilson, W. P. Fife · Science · 1975 · 365 citations
Medicine, Dermatology, Oncology +11